°F to 86°F (15°C to 30°C).
•Safely throw away medicine that is out of date or that you no longer need. Ask your pharmacist how to safely throw away Vandetanib tablets.
Keep Vandetanib and all medicines out of the reach of children.
General information about Vandetanib.
Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use Vandetanib for a condition for which it was not prescribed. Do not give Vandetanib to other people, even if they have the same symptoms you have. It may harm them.
This Medication Guide summarizes important information about Vandetanib. If you would like more information, talk with your healthcare provider. You can ask your healthcare provider or pharmacist for information about Vandetanib that is written for health professionals.
For more information, go to www.Vandetanib.com or call 1-800-236-9933.
What are the ingredients in Vandetanib?
Active ingredient: Vandetanib
Inactive ingredients:
Tablet core: calcium hydrogen phosphate dihydrate, microcrystalline cellulose, crospovidone, povidone, and magnesium stearate
Tablet coating:hypromellose 2910, macrogol 300, and titanium dioxide E171
This Medication Guide has been approved by the U.S. Food and Drug Administration.
Distirbuted by:
AstraZeneca Pharmaceuticals LP
Wilmington, DE 19850
Issued 04-06–2011
©AstraZeneca 2011
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Vandetanib
Vandetanib tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:0310-7810
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Vandetanib (Vandetanib) Vandetanib 100 mg
Inactive Ingredients
Ingredient Name Strength
DIBASIC CALCIUM PHOSPHATE DIHYDRATE
CELLULOSE, MICROCRYSTALLINE
CROSPOVIDONE
POVIDONE
MAGNESIUM STEARATE
HYPROMELLOSES
TITANIUM DIOXIDE
WATER
POLYETHYLENE GLYCOL 300
Product Characteristics
Color WHITE Score no score
Shape ROUND (biconvex) Size 9mm
Flavor Imprint Code Z;100
Contains
Packaging
Item Code Package Description
1 NDC:0310-7810-30 30 TABLET (TABLET) in 1 BOTTLE, PLASTIC
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA022405 04/21/2011
Vandetanib
Vandetanib tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:0310-7830
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Vandetanib (Vandetanib) Vandetanib 300 mg
Inactive Ingredients
Ingredient Name Strength
DIBASIC CALCIUM PHOSPHATE DIHYDRATE
CELLULOSE, MICROCRYSTALLINE
CROSPOVIDONE
POVIDONE
MAGNESIUM STEARATE
HYPROMELLOSES
TITANIUM DIOXIDE
WATER
POLYETHYLENE GLYCOL 300
Product Characteris |
